Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis — Stella

Recruiting

Back to Coronary Disease trials

Trial locations(1 site)

China

FuWai hospital, Beijing

Key details

Sponsor

Fu Wai Hospital, Beijing, China

Enrollment target

~10,000 participants

Started

January 2025

Primary completion

September 2027

Age range

18 Years – 45 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov